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Abstract. Activated rhoA, a ras-related GTP-binding 
protein, stimulates the appearance of stress fibers, focal 
adhesions, and tyrosine phosphorylation in quiescent 
cells (Ridley, A.J., and A. Hall, 1992. Cell. 70:389-399). 
The pathway by which rho triggers these events has not 
been elucidated. Many of the agents that activate rho 
(e.g., vasopressin, endothelin, lysophosphatidic acid) 
stimulate the contractility of smooth muscle and other 
cells. We have investigated whether rho's induction of 
stress fibers, focal adhesions, and tyrosine phosphoryla- 
tion is the result of its stimulation of contractility. We 
demonstrate that stimulation of fibroblasts with lyso- 
phosphatidic acid, which activates rho, induces myosin 
light chain phosphorylation. This precedes the forma- 
tion of stress fibers and focal adhesions and is accompa- 
nied by increased contractility. Inhibition of contractil- 
ity by several different mechanisms leads to inhibition 
of rho-induced stress fibers, focal adhesions, and ty- 
rosine phosphorylation. In addition, when contractility 
is inhibited, integrins disperse from focal adhesions as 
stress fibers and focal adhesions disassemble. Con- 
versely, upon stimulation of contractility, diffusely dis- 
tributed integrins are aggregated into focal adhesions. 
These results suggest that activated rho stimulates con- 
tractility, driving the formation of stress fibers and focal 
adhesions and elevating tyrosine phosphorylation. A 
model is proposed to account for how contractility 
could promote these events. 
F 
OCAL adhesions are sites where cells in culture ad- 
here strongly to the underlying extracellular matrix 
(ECM) 1  via specific members of the integrin family 
of ECM receptors (Burridge et al., 1988; Jockusch et al., 
1995). At their cytoplasmic  face, focal adhesions provide 
attachment for bundles of actin filaments (stress  fibers). 
More  than just  sites  of structural  linkage between  the 
ECM on the outside and the cytoskeleton on the inside, 
focal adhesions are regions of signal transduction. Compo- 
nents involved  in  multiple signal  transduction pathways 
have  been  identified  in  focal  adhesions  (Hynes,  1992; 
Juliano and Haskill,  1993; Clark and Brugge,  1995; Rich- 
ardson and Parsons,  1995; Schwartz et al., 1995) with most 
attention being directed toward tyrosine phosphorylation 
at these sites. Indeed, these are the most prominent sites 
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of tyrosine phosphorylation within fibroblasts  as well as 
many other cells in culture and, typically, the most promi- 
nently tyrosine-phosphorylated proteins in whole cell ly- 
sates are focal adhesion components, such as paxillin and 
the  tyrosine kinase,  FAK.  Tyrosine phosphorylation is 
stimulated under conditions of focal adhesion assembly 
when cells are plated on ECM substrata (Guan et al., 1991; 
Burridge et al., 1992; Hanks et al., 1992; Kornberg et al., 
1992). In addition, tyrosine phosphorylation is necessary 
for  focal  adhesion assembly,  although whether  this  in- 
volves focal adhesion components or upstream steps in the 
pathway has not been determined (Burridge et al., 1992). 
Several agents that induce the formation of focal adhe- 
sions  and  stress  fibers  in  quiescent  cells  lacking  these 
structures act via the low molecular GTP-binding protein, 
rhoA (Paterson et al., 1990; Ridley and Hall, 1992). Direct 
microinjection of activated rho into quiescent fibroblasts 
stimulates focal  adhesions and stress  fibers  to assemble 
rapidly. Conversely, inactivation of rho via ADP-ribosyla- 
tion catalyzed by the C3 exotransferase, blocks the assem- 
bly of these structures.  How rho stimulates these cytoskel- 
etal  events  has  not  been  resolved.  Because  there  is 
elevated pp125 focal adhesion kinase (FAK)  activity  in 
rho-stimulated cells (Zachary et al., 1992; Kumagai et al., 
1993; Barry and Critchley,  1994; Chrzanowska-Wodnicka 
and Burridge, 1994; Hordijk et al., 1994; Ridley and Hall, 
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tyrosine phosphorylation of FAK and prevent the assem- 
bly of focal adhesions and stress fibers (Burridge et al., 
1992; Chrzanowska-Wodnicka and Burridge, 1994; Ridley 
and Hall, 1994; Romer et al., 1994), the general assump- 
tion in the field has been that rho promotes focal adhesion 
and stress fiber formation by stimulating FAK activity. 
Many of the agents that stimulate focal adhesion and 
stress fiber formation via rho also induce cells to contract. 
For example, in smooth muscle, contractility is induced by 
lysophosphatidic acid (LPA), thrombin, vasopressin, en- 
dothelin, and bombesin (Said, 1983; Schmid et al., 1983; Liard, 
1984; Yanagisawa et al., 1988; for review see Moolenaar, 
1994). Some of these compounds also have been shown to 
stimulate contraction in other cell types. LPA causes chicken 
embryo fibroblasts and  human endothelial cells to con- 
tract (Kolodney and Elson, 1993) and induces neurite re- 
traction (Jalink  et  al.,  1994).  Similarly, thrombin  stimu- 
lates fibroblast and endothelial cell contraction (Giuliano 
and Taylor, 1990; Goekeler and Wysolmerski, 1995), and 
also  induces  neurite  retraction  (Jalink  and  Moolenaar, 
1992; Suidan et al., 1992). With neurite retraction, this ef- 
fect of LPA and thrombin has been shown to be mediated 
by rho, because  it is inhibited by the C3  exotransferase 
(Jalink et al., 1994).  In addition, activated rho has been 
shown to affect directly the contractility of permeabilized 
smooth muscle by decreasing the calcium requirement for 
contractility (Hirata et al., 1992). 
The stimulation of contractility by rho suggests a mecha- 
nism by which rho may induce the formation of stress fi- 
bers. Previously it was suggested that stress fibers arise as 
a result of isometric tension generated in ceils (Heath and 
Dunn, 1978; Burridge, 1981), Much evidence has accumu- 
lated  supporting  this  idea  and  that  contractility/tension 
also leads to focal adhesion assembly. For example, micro- 
injection into fibroblasts of antibodies that prevent myosin 
filament assembly and  a  functional contractile complex 
disrupt stress fibers (Honer et al.,  1988).  Contractility in 
nonmuscle cells is regulated by the phosphorylation of the 
20-kD  myosin light chain (MLC) catalyzed by a  myosin 
light  chain  kinase  (MLCK)  (Citi  and  Kendrick-Jones, 
1987). Diverse agents acting directly or indirectly to inhibit 
the MLCK, thereby inhibiting contractility, promote disas- 
sembly of stress fibers  and focal adhesions (Lamb et al., 
1988; Turner et al., 1989; Fernandez et al., 1990; Volberg et 
al., 1994). Conversely, when contractility is induced in cul- 
tured fibroblasts by depolymerizing microtubules, this is 
accompanied by increased assembly of stress fibers (Da- 
nowski, 1989) and focal adhesions (our unpublished obser- 
vations). 
In this paper, we have asked whether rho induces the as- 
sembly of focal adhesions and stress fibers by stimulating 
contractility. We  have  examined MLC phosphorylation 
and fibroblast contractility in response to rho activation. 
In addition, we have investigated the effects of agents that 
block contractility, either by inhibiting the MLCK or by 
inhibiting actin-myosin interaction, on rho-induced stress 
fibers, focal adhesions, and tyrosine phosphorylation. Our 
results indicate that rho-stimulated contractility drives the 
formation of stress fibers and focal adhesions, and elevates 
the  tyrosine phosphorylation of focal adhesion  compo- 
nents. 
Materials and Methods 
Cell Culture and Inhibitors of Contractility 
Balb/c 3T3 Clone A31 (Balb/c) fibroblasts (American Type Culture Col- 
lection, Rockville, MD), were grown in DME  (Life Technologies, Inc., 
Grand Island, NY), with 100 U/ml penicillin, 100 p~g/ml streptomycin, and 
250 ng/ml amphotericin B as fungizone, supplemented with 10% bovine 
calf serum (BCS; JRH Biosciences, Lenexa, KS). To obtain quiescence, 
cells were seeded at identical density in tissue culture dishes and main- 
tained in the culture medium with serum until they reached confluence. 
The cells were then extensively washed and starved in serum-free culture 
medium for 2-4 h. Quiescent, serum-starved cells were stimulated with 
culture medium containing 2 }xg/ml LPA (1-oleoyl-2-hydroxy-sn-glycero- 
3-phosphate, monosodium salt in 1-t20; Avanti Polar Lipids, Alabaster, AL). 
In  some  experiments inhibitors were  used:  an  inhibitor  of MLCK, 
KT5926  (Calbiochem Corp., La Jolla, CA) was used at 15 ~M; 1-(5-iso- 
quinolinylsulfonyl)-2-methylpiperazine (H7;  Sigma  Chemical  Co.,  St. 
Louis, MO) was used at 300 IxM final concentration; an inhibitor of actin- 
myosin interactions, 2,3-butanedione 2-monoxime (BDM; Sigma Chemi- 
cal Co.) was used at 20 mM. These compounds were added to the culture 
media during stimulation with LPA. To determine the effect of BDM on 
cellular ATP levels, ATP was measured using a luciferin/luciferase assay 
kit (Enlighten; Promega Corp., Madison, WI). 
Silicone Rubber Substrates 
To visualize cell contractility, flexible rubber substrates have been gener- 
ated by a modification of the protocol of Harris et al. (1980). Silicone rub- 
ber  (dimethyl polysiloxane, viscosity: 10,000-60,000  centistokes; Sigma 
Chemical Co.) was aliquoted into tissue culture dishes and allowed to 
spread for 1-2 h. The top of the silicone was then coated with a thin layer 
of gold-palladium using a cold sputter coater. The UV glow discharge that 
occurred during the gold-palladium coating served to polymerize the sili- 
cone rubber. The thin layer of gold-palladium decreased the hydrophobic 
nature of the rubber surface and enhanced the adhesion and spreading of 
ceils plated onto this surface. Cells were plated on the gold-coated, poly- 
merized flexible rubber and processed as described above for cells plated 
on tissue culture plastic. 
Immunofluorescence Microscopy 
Immunofluorescence  was  essentially  performed  as  described  before 
(Chrzanowska-Wodnicka and Burridge, 1994). Actin was stained with 400 
mU/ml TRITC-phalloidin (Molecular Probes, Inc., Eugene, OR), myosin 
was stained with a polyclonal anti-platelet myosin antibody (Kawamoto 
and Adelstein, 1987; a  kind gift from Dr. Robert Adelstein, NIH) fol- 
lowed by FITCqabeled goat anti-mouse IgG (Chemicon International, 
Inc., Temecula, CA). Phosphotyrosine was visualized using antiphospho- 
tyrosine, py20 (Transduction Laboratories, Lexington, KY), vinculin was 
stained with an mAb (7f9), kindly provided by Dr. Alexey Belkin, Univer- 
sity of North Carolina, Chapel Hill (Glukhova et al., 1990) followed by 
TRITC- or FITC-labeled goat anti-mouse IgG. Integrins were detected 
either with an affinity-purified rabbit antibody directed against the [M cy- 
toplasmic domain, kindly provided by Dr. Crispin Taylor, University of 
North Carolina, Chapel Hill, or with a goat antibody directed against the 
ct5131 complex, kindly provided by Dr. Rudy Juliano, University of North 
Carolina, Chapel Hill, followed by TRITC- or FITC-labeled donkey anti- 
rabbit or rabbit anti-goat IgG. Cells microinjected with recombinant pro- 
teins were visualized by staining with rabbit anti-GST  IgG (Molecular 
Probes, Inc.) followed by an FITC-labeled goat anti-rabbit IgG (Chemi- 
con International, Inc.). 
Analysis of Tyrosine Phosphorylation of Focal 
Adhesion Proteins 
For analysis of tyrosine phosphorylation in focal adhesion proteins, immu- 
noprecipitates from whole cell lysates were analyzed by Western blotting 
as described before (Chrzanowska-Wodnicka and Burridge, 1994). Briefly, 
cells were lysed on ice with cold lysis buffer consisting of TBS (150 mM 
NaCI,  50  mM Tris-Cl, pH  7.6)  with 0.1%  sodium  azide, 0.1%  Triton 
X-100, 0.1% sodium deoxycholate, 2 mM EDTA, 2 mM EGTA, 1 mM so- 
dium orthovanadate, and 25 }xg/ml  leupeptin. The lysates were clarified by 
a  10-min centrifugation at 13,000 g. Supernatants were either incubated 
with anti-paxillin or anti-FAK monoclonal IgG for 2-4 h at 4°C, followed 
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national, Inc.). Proteins bound to the sepharose were dissolved in SDS- 
sample buffer, separated by electrophoresis on 7.5% polyacrylamide gels 
(Laemmli, 1970)  and transferred electrophoretically to nitrocellulose. Ni- 
trocellulose was blocked with 2% cold water fish gelatin (Sigma Chemical 
Co.) in TBSTB (TBS with 0.1% BSA and 0.05% Tween 20) for 20-30 min. 
The nitrocellulose was then incubated for 45 rain with anti-phosphoty- 
rosine IgG conjugated to HRP, py20-HRP (ICN Biochemicals Inc., Irvine, 
CA) and extensively washed with TBSTB and TBS. Enhanced chemilumi- 
nescence (Amersham International, Buckinghamshire, UK) was used to 
develop the blots. Immunoblots were stripped in 62.5 mM Tris-HCl, pH 
6.75, 2% sodium dodecyl sulfate, and 100 mM 13-mercaptoethanol at 55°C 
for 45 min. Stripped blots were washed in TBS and reprobed with 2A7, 
anti-FAK monoclonal IgG  (Upstate  Biotechnology, Inc.,  Lake  Placid, 
NY), or with anti-paxiUin antibody in TBSTB. After washing in TBSTB 
the  blots  were  incubated  with  HRP-conjugated  goat  anti-mouse IgG 
(Jackson Immunoresearch Laboratories, West Grove, PA). 
Purification and Microinjection of 
Recombinant Proteins 
Recombinant Vall4rhoA  (a gift from Dr.  A. Hall, University College, 
London, UK) was expressed as a glutathione-S-transferase (GST) fusion 
protein in Escherichia coli.  GST was also expressed in E. coli.  As a con- 
trol, some cells were injected with GST alone expressed in E.  coli.  Pro- 
teins were purified on glutathione agarose beads as described before (Rid- 
ley et al., 1992).  Proteins were released from beads by triple elution with 
25 mM reduced glutathione in a  buffer (50 mM Tris-C1, pH 7.5, 50 mM 
NaC1, 5 mM MgC12, 1 mM DTT, 1 mM PMSF), dialyzed against microin- 
jection buffer (50 mM Tris, pH 7.5, 50 mM NaC1, 5 mM MgC12, 0.1 mM 
DTr)  and concentrated  to  2-7 mg/ml using a  Centricon concentrator 
(Amicon Inc., Beverly, MA). Purified proteins were loaded by capillarity 
into needles pulled on a  Brown-Flaming micropipette puller (Sutter In- 
strument Co.)  and injected into cells as described previously (Burridge 
and Feramisco, 1980).  Cells were injected for 15-30 min and then incu- 
bated at 37°C in an atmosphere of 10% CO2 for varying time intervals ac- 
cording to the experiment. In some experiments inhibitors were present 
during the injection and after incubation. 
Cell Labeling, Myosin Immunoprecipitation, and 
Quantitation of  Myosin Light Chain Phosphorylation 
For analysis of MLC phosphorylation a procedure was adapted from the 
work of Goekeler and Wysolmerski (1995). Cells were labeled with trans- 
35S-label (70% L-methionine [35S] +  L-cysteine [35S]) (ICN Biochemicals, 
Inc.) and [32P]orthophosphoric acid (ICN Biochemicals, Inc.). The double 
labeling of cells allowed us to quantitate the incorporation of phosphate 
into  MLC  relative  to  the  amount of myosin immunoprecipitated. For 
these experiments cells were plated in 24-well dishes at identical density in 
10%  BCS in DMEM, grown to confluency, washed once in phosphate- 
free Eagle's medium (Life Technologies, Inc.), and labeled with 100 ixCi/ 
ml trans-35S-label and 125 p.Ci/ml [32p]orthophosphoric acid in tissue cul- 
ture phosphate-free media containing 2%  BCS for 16-40 h. Cells were 
starved by washing in serum-free (phosphate-free) media for 2 h and then 
stimulated with LPA in the presence or absence of inhibitors, as described 
above. Medium was removed and cells were lysed by scraping in 150 p.l of 
ice-cold buffer A,  (25  mM Tris-HC1, pH 8.0,  300 mM NaC1,  100 mM 
Na4P207, 75 mM NaF, 5 mM EGTA, 5 mM EDTA, 10 p,g aprotinin, and 
10 ~g leupeptin). After scraping, the dishes were rinsed once with 50 p.l of 
buffer A  which was combined with the lysate. These were centrifuged at 
132,000 g for 10 min in a centrifuge (TL-100; Beckman Instruments, Ful- 
lerton, CA). The supernatants were incubated with 3 p,l of a  polyclonal 
rabbit anti-platelet myosin IgG fraction (a kind gift from Dr. R.S. Adel- 
stein) and 100 ixl of a 10% suspension of protein A-Sepharose in buffer A. 
The pellets were washed once in buffer A and two times in buffer A with a 
lower concentration of NaC1 (100 mM). The samples were boiled in sam- 
ple buffer and electrophoresed on  15%  SDS-polyacrylamide gels. The 
gels were stained with Coomassie blue, destained, dried, and exposed to a 
phosphorimaging screen (PhosphorImager, Molecular Dynamics) or x-ray 
film (Eastman-Kodak Co., Rochester, NY). 
Quantitation of 32p incorporation into MLC was performed using the 
phosphorImager as follows (Johnston et al., 1991).  Double-labeled sam- 
ples  were  exposed  to  phosphorimaging screens directly  and  the  total 
amount of radioactivity  (35S +  32p) was quantitated  for  myosin heavy 
chains (MHCs) and MLCs (the position of bands was established by run- 
ning a sample of purified smooth muscle myosin in parallel to the labeled 
samples). A  second exposure was obtained in which a filter was present 
between the gel and the phosphorimaging screen so as to block 35S radia- 
tion. The filter used was a triple layer heavy-duty Reynolds aluminum foil. 
This attenuated the detection of 35S to <1%, while detection of 32p re- 
mained at >97%.  The amount of 35S was calculated by subtracting the 
number of counts for each myosin band obtained with the filter present 
(which represents 97% of 32p), adjusted to 100% 32p, from the number of 
counts obtained without the filter (total 32p +  35S)" The number of 32p 
counts from each MLC sample was divided by the number of 35S counts 
from the corresponding MHC. This procedure  allowed  us to  calculate 
MLC phosphorylation relative to the amount of myosin in each immuno- 
precipitate. 
Results 
Inhibitors of  Actin-Myosin Interaction Block 
LPA-stimulated Contractility 
LPA induces the formation of stress fibers and focal adhe- 
sions in quiescent fibroblasts by a mechanism dependent 
on rho (Ridley and Hall, 1992).  Previous studies have indi- 
cated that LPA can stimulate contractility of chicken em- 
bryo fibroblasts (Kolodney and Elson,  1993). To explore 
whether LPA induces contractility in quiescent Balb/c 3T3 
cells, we have used a  modification of the flexible rubber 
substrate assay of Harris et al.  (1980).  Confluent cells in 
the  presence of serum wrinkle  the  substrate  extensively 
(Fig.  1).  Starvation  of cells in  serum-free media for 2  h 
leads to a  relaxation of the wrinkles generated by cells. 
Stimulation of these quiescent cells with LPA rapidly re- 
stores wrinkles in the substrate. The time course of the re- 
appearance of the wrinkles in the substrate correlates well 
with the time course of reappearance of stress fibers and 
focal adhesions and increased tyrosine phosphorylation in 
focal adhesions. Increased wrinkling can be seen within 5 
min of stimulation with LPA. At this time stress fibers and 
focal adhesions become visible in  cells grown  on plastic 
(Ridley and Hall, 1992,  see below) and LPA-induced ty- 
rosine  phosphorylation  of  focal  adhesion  components 
peaks (Seufferlein and Rozengurt, 1994). 
We have used several inhibitors of actin-myosin interac- 
tion with distinct modes of action to block LPA-induced 
contractility of Balb/c 3T3 cells, using the flexible rubber 
substrates as an assay. KT5926 is an inhibitor of MLCK, a 
key enzyme in the regulation of smooth muscle and non- 
muscle cell contractility (Nakanishi et al., 1990).  KT5926 
inhibits MLCK phosphorylation of the myosin regulatory 
light chain (MLC), which in turn inhibits actomyosin con- 
tractility. Butanedione-2-monoxime (BDM) has been used 
by several groups to inhibit muscle contractility. BDM inhib- 
its muscle myosin ATPase activity (Higuchi and Takemori, 
1989) by slowing the release of phosphate from myosin af- 
ter ATP hydrolysis (McKillop et al.,  1994).  Cramer and 
Mitchison (1995) have shown that BDM also inhibits the 
ATPase activity of nonmuscle myosin II, as well as several 
of the unconventional myosins. Compound H7 (1-(5-iso- 
quinolinylsulfonyl)-2-methylpiperazine), a  broad specific- 
ity kinase inhibitor, often used to inhibit protein kinase C 
(PKC), has been shown to inhibit actomyosin contractility 
in fibroblasts and epithelial cells in a way that is indepen- 
dent of its action on PKC (Volberg et al., 1994).  BDM, H7, 
or KT5926 were added with LPA to serum-starved Balb/c 
3T3 cells plated on the flexible rubber substrates. In each 
Chrzanowska-Wodnicka and Burridge Rho and Contractility  1405 Figure 1.  LPA stimulates fibroblast contractility. Balb/c 3T3 cells are plated on silicon rubber substrates. In the presence of serum, cells 
generate tension on the underlying substrate that is revealed by wrinkles in the rubber. Quiescence, induced by serum starvation of the 
cells for 2 h, leads to relaxation of tension and loss of wrinkles (top). Treatment of quiescent cells with LPA stimulates reappearance of 
wrinkles in the substrate, here shown at 1 h after stimulation. This behavior of cells in response to LPA is blocked by BDM, KT5926 
(middle and bottom panels, respectively), and H7 (data not shown). Upon removal of the inhibitors (here shown after 1 h), wrinkles in 
the substrate reappear, indicating reversibility. Each panel in a row represents the same field of view. Bar, 100 txm. 
case, these drugs inhibited the development of wrinkles in 
the substrate induced by LPA treatment of quiescent cells 
(Fig.  1, and data not shown), indicating that they blocked 
LPA-stimulated contractility. After 1 h, the medium con- 
taining the drugs was replaced with normal medium and 
10% serum. This led to extensive wrinkling of the underly- 
ing substrate by the cells within 5 min. 
LPA-stimulated Myosin Light Chain Phosphorylation Is 
Blocked by Inhibitors of Contractility 
We analyzed the level of MLC phosphorylation in quies- 
cent cells  and cells stimulated with LPA in the absence or 
presence of the inhibitors, BDM, H7, and KT5926. Myosin 
was immunoprecipitated from cells labeled simultaneously 
with [32p]orthophosphate and [35S]methionine/[35S]cysteine. 
The level of 32p incorporation into MLCs was calculated 
relative to the amount of 35S incorporation into the MHC 
in the same immunoprecipitated samples, to account for 
variable protein content in the immunoprecipitates, as de- 
scribed  in  Materials  and  Methods.  This  double-labeling 
protocol improves quantitation of the level of phosphate 
incorporation into MLCs occurring during stimulation or 
inhibition (Goekeler and Wysolmerski, 1995). The results 
are  presented  in  Fig.  2.  LPA  stimulates  an  increase  in 
MLC phosphorylation that is blocked by BDM, H7, and 
KT5926. Although BDM is an inhibitor of myosin ATPase 
activity, previous studies have also noted decreased MLC 
phosphorylation (Osterman  et  al.,  1993;  Siegman  et  al., 
1994). With BDM and H7, the level of MLC phosphoryla- 
tion was depressed even below that found in the quiescent 
cells.  For most  experiments,  MLC phosphorylation was 
measured at 10 min after LPA stimulation. When a time 
course  of MLC  phosphorylation was  investigated,  LPA 
treatment for 1 min was sufficient to stimulate nearly peak 
phosphorylation (data  not shown). This  was more rapid 
than the appearance of stress fibers and focal adhesions, 
which  were  visible  after  5  min,  but  were  usually  most 
prominent after 20 min of treatment with  LPA (see  be- 
low). 
Myosin Relocalizes to Stress Fibers upon 
LPA Stimulation 
Phosphorylation of MLCs leads to a conformational changes 
in myosin enabling it to assemble into filaments and pro- 
motes  its  productive  interaction  with  F-actin  (Citi  and 
Kendrick-Jones,  1987; Tan et  al.,  1992).  We studied  the 
The Journal of Cell Biology, Volume 133, 1996  1406 Figure 2.  Myosin  light  chain  phosphorylation is stimulated  by 
LPA. (A) Quantitation of MLC phosphorylation.  The level of 32p 
incorporation into MLCs was calculated relative to the amount of 
35S incorporation into the myosin heavy chains in the same sam- 
ple, as described  in Materials  and Methods.  Stimulation  of quies- 
cent cells with LPA for 10 min leads to an 80-100%  increase  in 
MLC phosphorylation.  This response to LPA is inhibited  when 
BDM, H7, or KT5926 are present during stimulation.  MLC phos- 
phorylation is expressed relative to the level of MLC phosphory- 
lation in quiescent cells (100%). Values shown are the means 
+/- SEM of three different experiments.  (B) Autoradiograph of 
myosin light chains immunoprecipitated from [32p] and [3ss](me- 
thionine  and cysteine)-labeled cells under different conditions of 
stimulation  and inhibition.  Quiescent cells (SF) were stimulated 
with LPA for 10 min (LPA), or with LPA and BDM (BDM), or 
with LPA and H7 (H7), or LPA and KT5926 (KT). 
distribution of myosin in quiescent cells and after stimula- 
tion  with LPA  (Fig.  3).  In quiescent  cells myosin is dis- 
persed  throughout  the  cytoplasm and  reveals very little 
detectable  organization  at  the  level  of light  microscopy 
(Fig. 3 A). Stimulation with LPA induces rapid reorgani- 
zation of myosin into stress fibers and generates a charac- 
teristic periodic staining pattern that is not detectable in 
quiescent  cells  (Fig.  3  B).  The  time course  of this  rear- 
rangement of myosin upon LPA treatment paralleled that 
of actin,  with  prominent  stress fiber staining  being seen 
within 20 min of stimulation. 
Inhibitors  of Contractility  Block LPA-stimulated Stress 
Fibers, Focal Adhesions, and Tyrosine Phosphorylation 
To investigate the possible role of contractility in the for- 
mation of stress fibers and focal adhesions we have exam- 
ined the effects of the inhibitors of actin-myosin contrac- 
tility on the formation of these structures induced by LPA. 
BDM, H7, and KT5926 all inhibit LPA-induced formation 
of stress fibers and focal adhesions in Balb/c 3T3 cells (Fig. 
4).  Essentially identical results were obtained with Swiss 
3T3 cells (data not shown). These three inhibitors,  how- 
ever, result in different morphologies, as seen in Fig. 4, G, 
J, and M. The differences may reflect additional effects of 
these inhibitors on other kinases or enzymes. 
Tyrosine phosphorylation of several focal adhesion pro- 
teins,  including  FAK,  paxillin,  tensin,  and  p130,  occurs 
during  the  formation of focal adhesions  when  quiescent 
cells are stimulated with LPA (Kumagai et al., 1993; Barry 
and  Critchley,  1994;  Chrzanowska-Wodnicka  and  Burr- 
idge,  1994;  Hordijk  et  al.,  1994;  Ridley  and  Hall,  1994; 
Seufferlein  and  Rozengurt,  1994)  and  when  cells  are 
plated on fibronectin (Guan et al.,  1991;  Burridge  et al., 
1992; Guan and Shalloway, 1992; Hanks et al., 1992; Bock- 
holt and Burridge, 1993;  Petch et al., 1995).  LPA induces 
increased  phosphotyrosine  staining  in  focal  adhesions 
(Fig. 4 F), compared with quiescent cells (Fig. 4 C) (Barry 
and  Critchley,  1994;  Chrzanowska-Wodnicka  and  Burr- 
idge, 1994; Seufferlein and Rozengurt, 1994). When BDM, 
H7,  and  KT5926  are  present  during  LPA  stimulation, 
phosphotyrosine staining in focal adhesions is diminished 
(Fig. 4, I, L, and O). This immunofluorescence data corre- 
late with biochemical analysis of tyrosine-phosphorylated 
proteins in cells under different conditions of stimulation 
and inhibition. As reported before, LPA induces increased 
tyrosine phosphorylation of several focal adhesion compo- 
nents. Here we have specifically examined two of the most 
prominent  tyrosine-phosphorylated  focal  adhesion  pro- 
teins, FAK and paxillin (Fig. 5, A  and B). BDM, KT5926, 
and  H7  all inhibit  the  LPA-induced  increase  in  tyrosine 
phosphorylation of these proteins. With BDM and H7 the 
level of tyrosine  phosphorylation  is  decreased  to  below 
that found in quiescent cells. KT5926 had the least effect 
on tyrosine phosphorylation. Of the three inhibitors at the 
respective concentrations used, KT5926 was generally the 
least  effective  at  inhibiting  MLC  phosphorylation,  con- 
tractility, and the formation of stress fibers and focal adhe- 
sions. All three inhibitors  appeared to decrease the level 
of tyrosine phosphorylation more  in  paxillin  than  FAK. 
This may be due in part to paxillin being downstream of 
FAK, with changes in the signal being amplified in down- 
stream targets. Consistent with this, LPA induces a greater 
change  in  the  tyrosine  phosphorylation  of paxillin  than 
FAK.  FAK  is  phosphorylated  on  multiple  tyrosines 
(Schwartz et al., 1995), some of which may be less affected 
or unaffected by LPA stimulation. This would also tend to 
lessen the apparent change in tyrosine phosphorylation of 
FAK in response to LPA or inhibition of LPA action. 
Rho-induced Stress Fibers, Focal Adhesions, and 
Tyrosine Phosphorylation  Are Blocked by Inhibitors 
of Contractility 
The effects of LPA on the cytoskeleton have been shown 
to be mediated by rho, but the steps between LPA and rho 
have not  been fully elucidated.  We wished to determine 
whether  the  inhibitors  of contractility that  block the  ac- 
tions of LPA act upstream or downstream of rho. To in- 
vestigate this question, we explored the effects of these in- 
hibitors of actomyosin contractility on cells microinjected 
with recombinant rho (Vall4rho). As described previously 
(Ridley and Hall,  1992),  activated rho induced  the  rapid 
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sin  reorganization  in  quies- 
cent cells. The distribution of 
myosin in quiescent  (A) and 
LPA-stimulated  (B)  cells 
has been visualized by stain- 
ing with anti-myosin antibod- 
ies. In quiescent cells myosin 
is  diffusely  distributed 
throughout  the  cytoplasm 
(A).  Stimulation  with  LPA 
for 20 min induces reorgani- 
zation  of myosin into stress 
fibers (B). Bar, 20 Ixm. 
formation of stress fibers and focal adhesions in injected 
cell  s (Fig. 6, A  and D). However, when BDM or H7 were 
present  during  injections,  the  formation of stress  fibers 
(Fig. 6, B and C) and focal adhesions (Fig. 6 H) was inhib- 
ited. Similar results were found with Swiss 3T3 cells (data 
not shown).  In  some  cells,  there  appeared  to  be  an  in- 
crease in actin staining in the presence of these inhibitors 
without the formation of large stress fibers, suggesting that 
actin polymerization induced by rho had not been inhib- 
ited, but that the assembly of the filaments into stress fi- 
bers  had.  BDM  and H7 greatly decreased the phospho- 
tyrosine staining  in  focal adhesions  in  rho-injected cells 
(Fig. 6, E  and F, compared with Fig. 6 D). These results 
suggest that rho-induced assembly of stress fibers and fo- 
cal adhesions involves stimulation of contractility. 
Contractility Modulates the Distribution of  lntegrins 
We wanted to follow the behavior and distribution of inte- 
grins during the transition of cells from quiescence, when 
cytoplasmic focal adhesion proteins are dispersed, to the 
stimulated  state,  when  focal  adhesions  are  prominent. 
However, mouse integrins  have been difficult to immu- 
nolocalize due to the lack of good anti-mouse integrin an- 
tibodies. Hence, we used another system to look at the be- 
havior  of  integrins  under  conditions  of  relaxation  and 
contraction.  Rat  embryo  fibroblasts  were  allowed  to 
spread  on  fibronectin  in  serum-free  media  and  were 
stained for actin (Fig. 7 A) and 131 integrin (Fig. 7 D). To 
mimic, the  quiescent  state  and  inhibit  contractility, cells 
were incubated in the presence of H7. The cells remained 
spread but the stress fibers (Fig. 7 B) and focal adhesions 
disassembled.  Notably,  the  distribution  of integrins  be- 
came diffuse and no focal adhesion staining was detected 
(Fig. 7  E).  Removal of H7 followed by stimulation with 
LPA induced the reformation of stress  fibers (Fig.  7  C) 
and relocalization of integrins into focal adhesions (Fig. 7 
F). This behavior of integrins is similar to that of other fo- 
cal adhesion proteins upon rho stimulation and indicates 
that integrins mediating adhesion to the underlying ECM 
can  be  rapidly  reorganized  into  focal  adhesions  while 
maintaining adhesion to the substrate. 
Discussion 
In this paper we have demonstrated that rho-induced for- 
mation of stress fibers, focal adhesions, and tyrosine phos- 
phorylation depends on contractility. Agents that inhibit 
contractility, either by inhibiting the MLCK or actin-myo- 
sin interaction, inhibit  all three events. At  the outset of 
this work we picked the three inhibitors used here because 
of their reported different modes of inhibiting actin-myo- 
sin force generation. KT5926 is a well-characterized inhib- 
itor of MLCK with relatively high specificity for this en- 
zyme in vitro (Nakanishi et al., 1990). BDM is an inhibitor 
of  skeletal  muscle  myosin  ATPase  (Fryer  et  al.,  1988; 
Horiuti et al.,  1988;  Higuchi and Takemori, 1989)  which 
acts by slowing the release of phosphate from the myosin 
head  following ATP hydrolysis (Herrmann  et  al.,  1993; 
McKillop et al., 1994).  BDM also inhibits the ATPase ac- 
tivity of nonmuscle myosins (Cramer and Mitchison, 1995). 
It was demonstrated, however, that BDM does not affect 
the ATPase activity of kinesin, nor does it affect several 
myosin-independent motile phenomena, such as actin po- 
lymerization, mitosis, and  the intracellular movement of 
Listeria monocytogenes (Cramer and Mitchison, 1995). Ef- 
fects of BDM on energy metabolism and ATP synthesis 
have been described (Hebisch et al., 1993).  However, we 
did not find significant differences in the levels of ATP in 
cells treated with BDM for the times used in our experi- 
ments  (data not shown). BDM has been reported to de- 
crease  MLC  phosphorylation  in  smooth  muscle  (Oster- 
man et al.,  1993) and depresses MLCK activity (Siegman 
et al., 1994). In our work we also have found that it inhibits 
MLC phosphorylation (Fig. 2). At present, we cannot say 
whether the inhibition of nonmuscle contractility by BDM 
is due to a direct action on the nonmuscle myosin ATPase, 
to inhibition of MLCK, or to a combination of both. 
The third inhibitor in this study, H7, was picked because 
of its  inhibition  of fibroblast and  epithelial  contractility 
(Volberg et al.,  1994).  H7 has often been used to inhibit 
PKC but Volberg and colleagues demonstrated that more 
specific PKC inhibitors had no effect on contractility. Sim- 
ilarly, we have found that the more specific PKC inhibitor, 
GF109203X  has  little effect on stress  fibers, focal adhe- 
sions, or tyrosine phosphorylation (data not shown). In ad- 
dition,  previous  work  demonstrated  that  the  effects of 
LPA on the cytoskeleton did not involve a PKC pathway 
(Ridley and Hall, 1994; Moolenaar, 1995)  and that LPA- 
and bombesin-induced tyrosine phosphorylation of FAK 
and paxillin are independent of PKC (Zachary et al., 1993; 
Seufferlein and Rozengurt,  1994).  Further evidence that 
The Journal of Cell Biology, Volume 133, 1996  1408 Figure 4.  LPA-stimulated stress fiber and focal adhesion assembly is blocked by inhibitors of contractility. Quiescent, serum-starved 
cells (A-C) were stimulated with LPA which led to increased stress fibers (D), focal adhesions (E), and tyrosine phosphorylation (F) in 
focal adhesions. These effects of LPA were abolished when BDM (G-0, H7 (J-L), or KT5926 (M-O) were present during LPA stimu- 
lation. Actin was stained with phalloidin in A, D, G, J, and M; vinculin  staining is shown in B, E, H, K, and N, and phosphotyrosine is 
shown in C, F,/, L, and O. Bar, 20 ~m. 
Chrzanowska-Wodnicka  and Burridge  Rho and Contractility  1409 Figure 5.  Inhibitors  of contractility  block LPA-induced tyrosine 
phosphorylation.  FAK (A) or paxillin (B) were immunoprecipi- 
tated from confluent,  quiescent  Balb/c 3T3 fibroblasts starved in 
the absence of serum for 2-4 h (lanes 1) and stimulated with 2 ~g/ 
ml LPA for 10 min (lanes 2), or with LPA and BDM (lanes 3), or 
with LPA and H7 (lanes 4), or with LPA and KT5926 (lanes 5). 
LPA elevated FAK and paxillin tyrosine phosphorylation.  This is 
inhibited  by BDM, H7, and KT5926. Blots were stripped and re- 
probed for FAK or paxillin to ensure equal protein loading (data 
not shown). 
we are not looking at the inhibition of PKC by H7 comes 
from the use of the PKC activator, PMA. Rather than hav- 
ing an opposite effect to H7, PMA also decreases contrac- 
tility  of fibroblasts  plated  on  flexible  rubber  substrates 
(Danowski  and  Harris,  1988;  our  unpublished  observa- 
tions). With H7, we have observed decreased MLC phos- 
phorylation suggesting that H7 may be acting directly on 
MLCK, even though H7 is reported to have a low activity 
for MLCK (Hidaka et al., 1984). We note, however, that a 
novel form of MLCK has recently been identified in non- 
muscle cells (Gallagher et al., 1995) and it is possible that 
H7 may be more effective at inhibiting this isoform than 
the  conventional  smooth  muscle  enzyme.  Alternatively, 
H7 may be acting on an upstream kinase between rho and 
the activation of MLC phosphorylation (see below). 
Within  1 min of LPA stimulation we detect significant 
elevation of MLC phosphorylation. In our hands this pre- 
cedes the detection of stress fibers, focal adhesions, and ty- 
rosine phosphorylation induced by rho injection or LPA 
treatment.  Similarly,  Kolodney  and  Elson  (1993)  found 
that  LPA led  to  a  rapid  stimulation  of contractility  and 
light  chain  phosphorylation  in  fibroblasts.  Likewise, 
Goekeler  and  Wysolmerski  (1995)  demonstrated  in 
thrombin-stimulated endothelial cells that MLC phospho- 
rylation and the development of tension preceded the re- 
organization  of actin  and  myosin  into  stress  fibers.  To- 
gether these results suggest that, in the pathway from rho, 
light chain phosphorylation and the resultant onset of con- 
tractility are upstream of stress fiber and  focal adhesion 
assembly, as well as upstream of the tyrosine phosphoryla- 
tion of focal adhesion components. 
The  elevation  of  MLC  phosphorylation  could  result 
from increased  MLCK activity or from decreased  phos- 
phatase activity. In permeabilized smooth muscle, C3 exo- 
transferase  promotes  dephosphorylation  of  MLCs,  sug- 
gesting that rho inhibits the MLC phosphatase  (Noda et 
al., 1995). Whether the elevation of MLC phosphorylation 
in nonmuscle cells is due to enhanced MLCK activity or 
depressed phosphatase activity, we suspect that, in either 
case,  a  kinase  cascade  is  involved.  The  rho-related  pro- 
teins, rac and cdc42, activate kinase cascades that resem- 
ble the ras/raf/MAP kinase pathway (Coso et al., 1995; Hill 
et al., 1995; Minden et al., 1995). Rho has been shown re- 
cently to bind and activate protein kinase N (PKN) (Amano 
et  al.,  1996;  Watanabe  et  al.,  1996)  and  to  bind  RhoA- 
binding kinase (Roket) (Leung et al., 1995). Both may be 
initial steps in rho-activated cascades. 
How could contractility lead to the formation of stress 
fibers, focal adhesions, and elevated tyrosine phosphoryla- 
tion? One scenario that we can envision is outlined in Fig. 
8.  In a  quiescent cell, the integrins responsible for adhe- 
sion to the underlying ECM are not clustered in focal ad- 
hesions but are dispersed over the ventral surface. At their 
cytoplasmic face, these integrins are linked to the actin cy- 
toskeleton, via proteins such as ot-actinin or talin, but in- 
stead  of being bundled  the  filaments are organized  as  a 
loose network.  Stimulation  by rho would  result in  MLC 
phosphorylation,  converting  the  myosin  from  a  relaxed 
conformation to an elongated conformation that can as- 
semble into  bipolar  filaments  (Citi  and  Kendrick-Jones, 
1987; Tan et al., 1992). Light chain phosphorylation would 
also promote the productive interaction of myosin heads 
with actin filaments, generating contractility and isometric 
tension.  The  actin filaments would become aligned both 
because of the tension generated and because myosin fila- 
ments are very effective at bundling F-actin. At the mem- 
brane, the bundled actin filaments would aggregate the in- 
tegrins  to  which  they  are  attached.  Associated  with  the 
integrins is FAK (Schaller et al., 1995). Clustering of inte- 
grins from the outside with antibodies has been shown to 
stimulate  FAK  activity (Kornberg et  al.,  1992).  Indeed, 
clustering rather than ligand occupancy appears to be crit- 
ical for FAK activation (Miyamoto et al., 1995).  Clustering 
from the  inside  by bundling  of the  associated  filaments 
would  also  be  expected to  stimulate  FAK  activity. This 
would account for the observed increase in tyrosine phos- 
phorylation of focal adhesion components that occurs in 
rho-stimulated cells. 
Tyrosine kinase inhibitors  block the  assembly of focal 
adhesions and stress fibers induced either by adhesion to 
ECM or by stimulation with activated rho (Burridge et al., 
1992;  Romer  et  al.,  1994;  Chrzanowska-Wodnicka  and 
Figure 6.  Rho induction  of stress fibers and focal adhesions  is blocked by inhibitors  of contractility.  Purified,  recombinant active rho 
(GST-Vall4rho) was microinjected  into quiescent  cells. Cells were stained for actin (A-C), phosphotyrosine (G-/) or vinculin (M and 
N). Injected cells were revealed by staining with anti-GST antibody (D-F, J-L, 0, and P). Recombinant activated rho induces stress fi- 
bers (A) and focal adhesions (M) and elevates phosphotyrosine staining (G) in focal adhesions. When BDM (B, H, and N) or H7 (C and 
/) are present during microinjection,  stress fibers are inhibited  (B and C) and focal adhesions do not form (H, I, and N). Control cells in- 
jected with GST alone did not induce stress fibers or focal adhesions (data not shown). Bar, 20 txm. 
The Journal of Cell Biology,  Volume 133, 1996  1410 Chrzanowska-Wodnicka and Burridge Rho and Contractility  1411 Figure 7.  Contractility  modulates the distribution  of integrins. REF 52 fibroblasts were plated on fibronectin  in serum-free conditions, 
stained at 90 min for actin (A) and 131 integrin (D). Cells were treated for 30 min with H7 and then stained for actin (B) and 131 integrin 
(E). After 30 min in H7, parallel cells were returned to serum-free medium containing LPA for 30 min and then stained for actin (C) 
and 131 integrin (F). Addition of H7 disassembles stress fibers and disperses integrins. Removal of H7 and stimulation with LPA induces 
reformation of stress fibers and clustering of integrins into focal adhesions. Bar, 20 ~m. 
Burridge, 1994; Ridley and Hall, 1994).  Because these in- 
hibitors decrease the phosphorylation of FAK, these find- 
ings have usually been interpreted as indicating a role for 
FAK in focal adhesion assembly. Evidence has been pre- 
sented, however, that FAK is not involved in focal adhe- 
sion or stress fiber assembly (Wilson et al., 1995; Ilic et al., 
1995).  Our  results  suggest  that  FAK  phosphorylation is 
downstream of rho-induced contractility, which aggregates 
integrins  into  focal  adhesions.  These  findings,  together 
with  the  previous  work  with  tyrosine  kinase  inhibitors, 
suggest that the  relevant tyrosine kinase regulating focal 
adhesion assembly is not FAK but one that is upstream of 
light chain phosphorylation. It will be important in the fu- 
ture to determine if any rho-activated kinases are targets 
for the tyrosine kinase inhibitors that prevent focal adhe- 
sion  assembly. Likewise it will be interesting  to  explore 
whether H7 is inhibiting MLC phosphorylation by acting 
on an upstream kinase. PKN, a rho-activated kinase, is a 
potential candidate, given that it is related to PKC (Mukai 
and Ono, 1994; Palmer et al., 1995). 
The balance between adhesion and contractility is com- 
plex. In response to isometric tension there may be a corn- 
pensatory increase in the adhesive strength of focal adhe- 
sions, for example by recruitment of additional integrins. 
When  the  contractile  force generated in stress fibers ex- 
ceeds the adhesive strength of focal adhesions, the adhe- 
sions would be released from the substrate. This may be 
important during cell migration when focal adhesions, par- 
ticularly  at  the  rear  of a  cell  need  to  be  disassembled. 
Studying permeabilized cells, Crowley and Horwitz (1995) 
found that  ATP-induced  contractility  does,  indeed,  pro- 
mote the disassembly of focal adhesions. Many of the fac- 
tors  that  regulate  adhesive  strength  may not  operate  in 
permeabilized cells and, with permeabilization, focal ad- 
hesions may be weakened by extraction of critical compo- 
nents. Together, these changes in permeabilized cells may 
result in the contractile force exceeding the strength of the 
adhesion, as observed by Crowley and Horwitz (1995). 
Although  there  is  a  large  body of evidence consistent 
with  contractility  generating  both stress fibers and  focal 
adhesions,  one previous study suggested that focal adhe- 
sions could form in the  apparent absence of stress fibers 
(Nobes and Hall, 1995).  In this work focal adhesions were 
induced by activated rho in the presence of low concentra- 
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Figure 8.  Mechanism of contractility-induced  focal adhesion  and 
stress fiber formation. In quiescent cells integrins are attached to 
the underlying  ECM, but dispersed  and not aggregated in focal 
adhesions. At the cytoplasmic face, integrins are attached to actin 
filaments through proteins such as ct-actinin and talin, but the fil- 
aments form a loose network and are not bundled.  Activation of 
rho results  in phosphorylation of MLCs. This leads to a confor- 
mational change in myosin, myosin filament assembly, and an ac- 
tive interaction with actin. The generation of tension  aligns the 
actin filaments and aggregates integrins in the plane of the mem- 
brane, stimulating  FAK activity and elevating tyrosine phospho- 
rylation. 
tions of cytochalasin D. Careful examination of their im- 
ages suggests that the focal adhesions in the cytochalasin- 
treated cells were still associated with bundles of actin fila- 
ments.  Although  the  concentration  of cytochalasin used 
may have prevented polymerization of additional actin in 
response to rho and may have induced some depolymer- 
ization, it was not destroying all the actin filaments in this 
experiment. One can imagine that the residual actin fila- 
ments were still sufficient to generate enough  tension to 
aggregate the integrins on the ventral surface and stimu- 
late focal adhesion formation. In general, cytochalasin has 
been found to inhibit FAK phosphorylation (Lipfert et al., 
1992;  Pelletier et al.,  1992;  Haimovich et al., 1993;  Bock- 
holt and Burridge, 1993; Seufferlein and Rozengurt, 1994). 
The requirement for an intact cytoskeleton for FAK to be 
activated has  always been  a  somewhat surprising  result. 
Our results suggest that an intact actin cytoskeleton is re- 
quired for FAK activation because contractility within the 
microfilament system is needed to aggregate integrins. 
The model we propose requires that integrins go from a 
dispersed, but ligand-bound state, to an aggregated ligand- 
bound  state,  found  in  focal adhesions.  With  mouse  3T3 
cells, it has been difficult to examine the behavior of inte- 
grins due to the paucity of reagents that detect mouse inte- 
grins. However, we have used a different cell system to ex- 
amine  the  behavior  of  integrins  in  cells  adhering  to 
fibronectin under conditions where contractility is inhib- 
ited or where it is stimulated. With the transition from a 
relaxed state to a contractile state, the integrin, a5131, goes 
from a  diffuse  distribution  to  being concentrated  within 
focal  adhesions,  consistent  with  the  predictions  of  our 
model.  Conversely, when  contractility  is  inhibited,  inte- 
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Figure 9.  Mechanism of rho regulation  of the actin cytoskeleton. 
Activation of rho is proposed to regulate the organization  of the 
actin  cytoskeleton by two synergistic  pathways.  One  pathway, 
possibly involving a kinase cascade, leads to inactivation  of myo- 
sin  phosphatase (MPP) or activation  of MLCK. This  elevates 
MLC phosphorylation, activating  myosin and  stimulating  con- 
tractility. Rho also stimulates the activity of PIP 5-kinase and ele- 
vates PIP2 levels in cells. PIPe has been shown to affect multiple 
actin-binding proteins in ways that should elevate actin polymer- 
ization and promote focal adhesion assembly (see text). 
grins disperse from focal adhesions as stress fibers and fo- 
cal adhesions disassemble. These observations imply that 
integrins can redistribute on the ventral surface of a cell in 
response to tension generated within stress fibers. The rel- 
atively low affinity of integrins for their ECM ligands (Kd 
10 -7 M) suggests a rapid off rate that would permit easy 
remodeling of integrin-ECM  interactions  in response to 
applied  tension,  while  at the  same time maintaining cell 
adhesion to the ECM substratum. 
Previous  studies  have  suggested  other  pathways  by 
which rho may affect cytoskeletal organization. In particu- 
lar, rho has been shown to stimulate the activity of phos- 
phatidylinositol 4-phosphate 5-kinase (PIP 5-K) leading to 
elevated phosphatidylinositol 4,5-biphosphate  (PIPe) lev- 
els in response to adhesion (Chong et al., 1994).  In turn, 
PIPe has been demonstrated to interact with actin-binding 
proteins such as profilin and gelsolin, promoting their dis- 
sociation from actin (Lassing and Lindberg, 1985; Janmey 
et al.,  1987). These effects of PIP2 would be expected to 
lead to increased actin polymerization. In addition,  work 
from this lab has recently demonstrated that PIP2 stimu- 
lates a conformational change in vinculin to expose cryptic 
actin-  and  talin-binding  sites  (Gilmore  and  Burridge, 
1996).  This effect of PIP  2 would  also be expected to en- 
hance the assembly of focal adhesions. Under normal con- 
ditions,  we  suspect  that  rho-stimulated  contractility  will 
synergize with the other cytoskeletal events triggered by 
elevated PIP2 levels, together contributing  to the forma- 
tion of stress fibers and focal adhesions (Fig. 9). 
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